InvestorNewsBreaks

Wednesday Sep 04, 2024 - 3:29 pm

InvestorNewsBreaks – MoneyShow Announces Agenda for This Month’s Virtual Expo on Income, Growth, Value

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, has announced its upcoming MoneyShow Virtual Expo – Income, Growth, and Value; the event is slated for Sept. 17–19, 2024, in an entirely digital format. According to the announcement, MoneyShow conferences have built a reputation for offering industry flagship events that offer world-class educational opportunities in trading and investing domains. MoneyShow…

Wednesday Sep 04, 2024 - 3:25 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO John Climaco will present at the event; his presentation will…

Wednesday Sep 04, 2024 - 3:04 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Three New Contracts for Its Emergency Communication Devices

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has secured three new contracts for its Emergency Communication Devices (“ECDs”). According to the announcement, Colonial Electric, a Knightscope Authorized Partner (“KAP”) and electrical contractor serving the Northeast, sold 4 K1 Blue Light Towers to a customer in New Jersey. Additionally, universities in California and Texas expanded their existing…

Wednesday Sep 04, 2024 - 2:10 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate Cancer

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, today announced that its subsidiary, Pearsanta, Inc., has submitted a grant application to the Prostate Cancer Research Program (“PCRP”) under the Department of Defense (“DoD”) Implementation Science Award funding mechanism. Pearsanta is seeking $2 million in non-dilutive funding to advance the early detection and management of prostate cancer. The Science Award,…

Wednesday Sep 04, 2024 - 1:18 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Completes First Shipment of Vehicles Purchased by Volt Mobility through $210M PO

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, announced the initial shipment of vehicles to fulfill a $210 million purchase contract with Volt Mobility, which is based in the United Arab Emirates (“UAE”). Volt has purchased 3,000 Mullen Class 1 and Class 3 EV cargo vans and trucks to be delivered over a 16-month period. The initial shipment of vehicles represents the first phase…

Wednesday Sep 04, 2024 - 1:06 pm

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Developing Fast-Track-Designated Treatment for Fibromyalgia

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, is developing TNX-102 SL, a new nonaddictive treatment for fibromyalgia, the prototypic nociplastic pain syndrome. According to a recent post, research into the causes and nature of pain is increasing; the post observed that there were more than 400 scientific presentations at the 2024 Word Congress on…

Wednesday Sep 04, 2024 - 12:59 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) is a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-based treatment options. The company today announced that its CEO, Doug Drysdale, will participate in a fireside chat and panel discussion at the H.C. Wainwright 26th Annual Global Investment Conference. The event will be held September 9-11, 2024, in New York, NY. Mr. Drysdale’s fireside chat will be…

Wednesday Sep 04, 2024 - 12:55 pm

InvestorNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Reports Early Return on Investment at SASB Gas Field, Shares August Performance

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided a production update for the SASB gas field, noting that the SASB revitalization program realized the complete payback of recent perforation costs. According to the update, the Guluc-2, South Akcakoca-2, West Akcakoca-1 and Akcakoca-3 wells started production over…

Wednesday Sep 04, 2024 - 12:28 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver ‘Breakthrough Treatment’ in Alzheimer’s Disease

IGC Pharma (NYSE American: IGC), an AI-powered, clinical-stage biotechnology company, is announcing the advancement of its proprietary formulation, IGC-AD1, an orally administered medication with a strong safety profile, toward clinical trials as a potential anti-amyloid disease-modifying treatment for Alzheimer’s disease. According to the announcement, IGC Pharma is positioned to make a significant contribution with IGC-AD1 following the FDA’s 2023 approval of Donanemab (Eli Lily) and…

Wednesday Sep 04, 2024 - 12:24 pm

InvestorNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) to Host Technology and Manufacturing Day

Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, has announced a Technology & Manufacturing Day. The company will host the event on Sept. 10, 2024, which will be livestreamed beginning at 8 a.m. PT from the company’s Arizona factory. According to the announcement, the event will showcase the company’s Lucid Gravity SUV and will cover enabling technologies as well as provide an…

Wednesday Sep 04, 2024 - 12:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Reaches Agreement to Extinguish $1.1M of Outstanding Debt, Convertible Notes

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, today announced that it has come to an agreement with Freight Opportunities LLC. The agreement will see the extinguishment of $906,000 of outstanding promissory notes…

Wednesday Sep 04, 2024 - 11:57 am

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Enters into Public Offering Agreement Estimated to Total $4.45M

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, has entered into a placement agency agreement. The agreement is for the purchase and sale of 8,106,584 shares of its common stock (or prefunded warrants in lieu thereof). The shares are offered at $0.55 per share (or $0.549 per prefunded warrant in lieu thereof). According to the announcement,…

Wednesday Sep 04, 2024 - 11:46 am

InvestorNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Makes Commitment to Transparency and Regulatory Compliance in Brazil

Meta (NASDAQ: META), known for its significant presence in the social media landscape through platforms like Facebook and Instagram, has recently made headlines with its commitment to transparency in Brazil. The company’s decision to inform Brazilian users about the use of their personal data for training generative artificial intelligence (“AI”) technologies marks a pivotal moment in the ongoing dialogue about data privacy and AI ethics.…

Wednesday Sep 04, 2024 - 11:40 am

InvestorNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor

Telomir Pharmaceuticals (NASDAQ: TELO), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, today announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel’s extensive career in pharmaceutical innovation spans over 40 years, during which he has been instrumental in the research, development, and regulatory approvals of numerous therapies across various therapeutic areas. Dr. Angel…

Wednesday Sep 04, 2024 - 11:40 am

InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Announce Verification of Uranium, Rare Earth Element Mineralization Discovery

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element (“REE”) and uranium sectors, is reporting the successful discovery of uranium and rare earth element mineralization during the 2024 exploration program at its Eastside property. According to the announcement, the assay results were analyzed and verified by a third party, the Saskatchewan Research Council (“SRC”)…

Wednesday Sep 04, 2024 - 11:07 am

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, is reporting its Q2 2024 financial results for the period ending July 31, 2024. According to the report, the company ended the quarter in a strong cash position, reinforcing its ability to advance the development of its lead product, AVERSA(TM) Fentanyl, with a New Drug Application (“NDA”) submission planned for the first half of 2025. The…

Wednesday Sep 04, 2024 - 11:03 am

InvestorNewsBreaks – WiSA Technologies, Inc. (NASDAQ: WISA) Executes Definitive Agreement to Create ‘Larger, More Dynamic Entity’ with Broad Reach

WiSA Technologies (NASDAQ: WISA) today announced the execution of a definitive asset purchase agreement to purchase the Datavault(R) intellectual property and information technology assets of privately held Data Vault Holdings Inc. WiSA will pay $210 million as consideration, consisting of 40 million shares of common stock to be issued at $5 per share plus a $10 million 3-year unsecured promissory note. The transaction is expected…

Wednesday Sep 04, 2024 - 10:37 am

InvestorNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Provides Update on Its Iska Iska Silver-Tin Polymetallic Project in Southwestern Bolivia

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, today provided an update on its Iska Iska silver-tin polymetallic project in Potosi Department, southern Bolivia. According to the update, an initial program of 5,700m of diamond drilling in 13 holes in the Santa Barbara starter pit area…

Wednesday Sep 04, 2024 - 10:28 am

InvestorNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Doses Five New Patients in UK ACHIEVE Phase 2b Trial

TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has dosed five new patients in the ongoing ACHIEVE phase 2b trial in the United Kingdom. According to the announcement, that brings the total number of patients dosed to six; five patients have received a second dose and two patients have received a third dose. The announcement noted…

Wednesday Sep 04, 2024 - 9:38 am

InvestorNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Leaders to Present at Upcoming Quantum World Congress 2024

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, will participate in this month’s Quantum World Congress. The three-day event is slated for Sept. 9-11, 2024, in Tysons, Virginia. Allison Schwartz, D-Wave’s global government relations and public affairs leader, will contribute to a dynamic workshop, titled “Quantum & Sustainability,” which…

Wednesday Sep 04, 2024 - 9:29 am

InvestorNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTC: CNIKF) Files Technical Report for Deloro Project Initial Resource

Canada Nickel (TSX.V: CNC) (OTC: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has filed an independent technical report supporting the initial mineral resource estimate for its wholly owned Deloro Nickel Sulphide Project, which is located near Timmins, Ontario. Effective Sept. 3, 2024, the report is titled “National Instrument 43-101 Mineral Resource Estimate and Technical Report on the Deloro Nickel-Cobalt Sulphide Project.”…

Tuesday Sep 03, 2024 - 2:48 pm

InvestorNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Additional Orders from European Governments Totaling $2.6M

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has received new orders valued at $2.6 million from different governments in Europe; the company anticipates fulfilling the orders in the next three months. The company offers PureSecurity Suite, an end-to-end electronic monitoring solution that features state-of-the-art GPS tracking, communication and monitoring technologies, as well as a secure software…

Tuesday Sep 03, 2024 - 1:16 pm

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Alignment with FDA on Development Pathway for Lomecel-B(TM) in HLHS

Longeveron (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, today announced a positive Type C meeting with the U.S. Food and Drug Administration (“FDA”). The meeting supported the advancement of Lomecel-B(TM), a proprietary, scalable, allogeneic, investigational cellular therapy currently being evaluated in a Phase 2b clinical trial (“ELPIS II”) for hypoplastic left heart syndrome…

Tuesday Sep 03, 2024 - 12:38 pm

InvestorNewsBreaks – Alphabet Inc.’s (NASDAQ: GOOGL) Strategic Expansion in India’s Digital Payment Sector

Alphabet’s (NASDAQ: GOOGL, GOOG) Google is making significant strides in India’s digital payment landscape through its Google Pay platform. By enhancing its partnership with India’s United Payments Interface (“UPI”), Google is introducing innovative features aimed at simplifying and improving financial transactions for millions of users. This move not only strengthens Google’s position in the fintech sector but also aligns with India’s push towards a more…

Tuesday Sep 03, 2024 - 12:27 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical company evaluating the pharmacokinetics of these compositions in animal studies.…

Tuesday Sep 03, 2024 - 12:25 pm

InvestorNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces Closing of Private Placement Final Tranche

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has closed on a nonbrokered private placement. In addition, the company has issued 8,925,055 units at $0.055 per unit, with each unit consisting of one common share of the company and one common share purchase warrant exercisable at a price of $0.07 until Aug. 29, 2029. Gross proceeds from the placement total an estimated $490,878. The…

Tuesday Sep 03, 2024 - 11:32 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in the most recent episode of IBN’s BioMedWire Podcast. During the episode, CNS Pharmaceuticals CEO John Climaco talks with podcast host Carmel Fisher to explain what sets CNSP’s Berubicin and new TPI-287 candidate apart from anything else…

Tuesday Sep 03, 2024 - 11:25 am

InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety. The company today announced that management will hold one-on-one meetings with investors and deliver a company presentation at the H.C. Wainwright 26th Annual Global Investment Conference, scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel. The recorded presentation will…

Tuesday Sep 03, 2024 - 11:23 am

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K

PaxMedica (OTC: PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, has entered into definitive agreements for the immediate exercise of certain outstanding warrants. The agreements outline the “purchase up to an aggregate of 4,423,080 shares of common stock of the originally issued in November 2023, having an exercise price of 1.30 per share, at a reduced exercise price of $0.20 per…

Tuesday Sep 03, 2024 - 11:16 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Management to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company today announced that its management will present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor…

Tuesday Sep 03, 2024 - 10:05 am

InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Welcomes Seasoned Investment Banker to Board of Directors

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced the appointment of Campbell Becher to its board of directors. The appointment became effective on September 1, 2024. Becher, who currently serves as the CEO of IberAmerican Lithium, has more than 20 years of experience in investment banking. “Campbell is a seasoned investment banker with…

Tuesday Sep 03, 2024 - 10:00 am

InvestorNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Receives Top-of-Class Uranium Sector Sustainability Rating, Ranks as Leading Uranium Mining Company

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has received a Sustainalytics Rating of 23.8. According to the announcement, the rating places UEC as the leading uranium mining company and in the top fifth percentile of the Diversified Metals and Mining Subindustry as rated by Morningstar Sustainalytics. “As the fastest-growing, North-American-focused uranium company, we are proud to have attained the leading…

Tuesday Sep 03, 2024 - 9:50 am

InvestorNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

RYVYL (NASDAQ: RVYL), a leading innovator of payment transaction solutions, today announced that it will participate at the H.C. Wainwright 26th Annual Global Investment Conference. The event is set for September 9-11, 2024, at the Lotte New York Palace Hotel in New York City. According to the announcement, Ben Errez, RYVYL Chairman and Co-Founder, and George Oliva, RYVYL Chief Financial Officer, will be in attendance…

Tuesday Sep 03, 2024 - 9:48 am

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), American West Metals Report Status Update on Drilling, Surveys at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade copper and gold deposits in Virginia and Nunavut, Canada, has released an update on drilling activities and geophysical surveys being conducted at the Storm Copper Project, located on Somerset Island, Nunavut. Highlights of the report indicate that drilling has surpassed 20,000 meters with 128 Reverse Circulation (“RC”) drill holes and…

Friday Aug 30, 2024 - 2:54 pm

InvestorNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Expands Partnership with Fiserv to Enhance Checkout Experiences

PayPal Holdings (NASDAQ: PYPL), a leading digital payments platform, has recently announced a significant expansion of its strategic partnership with Fiserv, Inc., aiming to enhance the checkout experiences across the United States. This collaboration is set to streamline the payment process, making it more efficient for users. PayPal, known for its robust payment solutions, is taking a step further in improving digital payment systems through…

Friday Aug 30, 2024 - 2:48 pm

InvestorNewsBreaks – MoneyShow Hosts Toronto Politics, Policy and Profits Event Next Month

MoneyShow, a leading producer of financial conferences for affluent investors active traders, and financial advisors, is reporting on the agenda for next month’s The MoneyShow Toronto — Outlook 2024–25 Politics, Policy and Profits Conference. MoneyShow is hosting the event, which is slated for Sept. 13–14, 2024. According to the announcement, MoneyShow conferences are designed to be dynamic industry events that provide participants with world-class educational insights…

Friday Aug 30, 2024 - 2:45 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer…

Friday Aug 30, 2024 - 2:41 pm

InvestorNewsBreaks – Upstream Releases New Episode of Upstream Up Close Twitter Series, Offers Insight into Navigating Market Downturns

Upstream, a MERJ Exchange stock market and global trading app, team hosted the 16th episode of its Upstream Up Close series on Twitter (X) Spaces. Upstream noted the release of the episode, explaining that the series features 10–15 minute discussions covering key topics in the world of digital collectibles, Web3 and trading on Upstream. Episode 16 specifically focused on the potential of blockchain technology to…

Friday Aug 30, 2024 - 2:15 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

Clene (NASDAQ: CLNN), a biopharmaceutical company, is at the forefront of transforming the treatment of neurodegenerative disorders like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead agent, CNM-Au8, targets the nicotinamide adenine dinucleotide (‘NAD+’) pathway to restore and protect neurological function. CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health. Mitochondrial dysfunction is a common pathway…

Friday Aug 30, 2024 - 2:15 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited about the new additions and confident that these highly experienced professionals will significantly contribute to the company’s mission of developing transformative therapies for neurodegenerative diseases.…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions